7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,772.71

+564.57

+0.73%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NSE - Delayed Quote INR

Mankind Pharma Limited (MANKIND.NS)

2,492.80 +23.50 (+0.95%)

At close: October 30 at 3:28:16 PM GMT+5:30

Mankind Pharma Ltd (NSE:MANKIND) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...

GuruFocus.com 5mo ago

MANKIND.NS
+0.95%
MANKIND.BO
Actimed Therapeutics Announces Important Licensing Agreement with Mankind Pharma

GlobeNewswire 11mo ago

MANKIND.NS
+0.95%
Mankind Pharma Ltd (NSE:MANKIND) (Q1 2027) Earnings Call Highlights: Chronic Portfolio Surges ...

GuruFocus.com 2mo ago

MANKIND.NS
+0.95%
MANKIND.BO
Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update

PR Newswire 5mo ago

TBPH

MANKIND.NS
+0.95%
Chandigarh University's Biotechnology & Pharmacy Students Secure 178 Placements with Leading Pharmaceutical and Biotechnology Companies

PR Newswire 3mo ago

SUNPHARMA.NS

GSK

MANKIND.NS
+0.95%
India Semaglutide Patent Expiry Could Drive 50% Price Drop in Weight-Loss Drugs

GuruFocus.com 7mo ago

NOVO-B.CO

FORTIS.NS

MANKIND.NS
+0.95%

Mobilize your Website

View Site in Mobile | Classic

Share by: